齐普罗与普罗波以及血液动力学不良事件的风险:对随机对照试验的试验顺序分析的元分析
Minmin Zhu1, Chong Zhao2, Jinjin Jian3
1Department of Anesthesiology and Pain Medicine, Wuxi No. 2 People's Hospital, Jiangnan University Medical Center, Affiliated Wuxi Clinical College of Nantong University, Wuxi, 214002, China.
BMC anesthesiology
|February 27, 2026
概括
在这次元分析中,西普罗与普罗波相比,显著降低了手术内低血压. 虽然有效,但由于证据的确定性适度,需要进一步研究.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 术内低血压带来了显著的术后风险.
- 齐普罗是一种新型麻醉剂,具有类似于普罗波的药理动力学.
- 它在预防手术内低血压方面的有效性需要研究.
研究的目的:
- 为了比较西普罗和普罗波之间手术内低血压的发生率.
- 评估二次结果,如呼吸抑制和注射疼痛.
- 用试验顺序分析来评估证据的稳定性.
主要方法:
- 一项对34项随机对照试验的元分析,涉及5,162名患者.
- 在PubMed,Embase和Cochrane图书馆搜索到2025年12月.
- 进行了子组分析和试验顺序分析.
主要成果:
- 西普罗显著降低了手术内低血压的风险 (RR=0.65).
- 与西普罗一起观察到的呼吸抑制,注射疼痛和低氧化症的发病率较低.
- 证据确定性被评为低至中等,其中有一些探索性发现.
结论:
- 西普罗显示出降低手术内低血压的潜力,而不是普罗波.
- 观察到可比的麻醉疗效.
- 由于证据有限,需要进一步进行高质量的试验.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Parenteral Anesthetics: Overview
820
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
820
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
233
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
233
Hazard Ratio
661
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
661
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
430
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
430
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
54
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
54

